Title:
MULTI-ARM TARGETING CONJUGATE
Document Type and Number:
WIPO Patent Application WO/2019/096096
Kind Code:
A1
Abstract:
Disclosed is an anti-cancer targeting conjugate modified by a multi-arm polymer, wherein modification by a water-soluble polymer can enhance the water solubility of the conjugate and increase a drug loading amount; when the targeting molecule is LRKLRKRLLLRKLRKRLL, the conjugate can increase brain targeting so as to make same pass through the blood brain barrier more easily, and can play the role of a brain-targeting peptide, allowing same to be at a higher concentration in a target tissue; and when the targeting molecule is folic acid, the conjugate can actively target tumor cells in which folate receptors are abundantly expressed, and better exert anti-tumor effects and enhance the targeting property.
Inventors:
YUAN JIANDONG (CN)
HUANG YANGQING (CN)
SONG YUNSONG (CN)
HUANG YANGQING (CN)
SONG YUNSONG (CN)
Application Number:
PCT/CN2018/115059
Publication Date:
May 23, 2019
Filing Date:
November 12, 2018
Export Citation:
Assignee:
BRIGHTGENE BIO MEDICAL TECH CO LTD (CN)
International Classes:
C08G65/333; A61K31/4745; A61P35/00; A61P35/04; C08G65/334
Domestic Patent References:
| WO2005028539A2 | 2005-03-31 | |||
| WO2011063156A2 | 2011-05-26 |
Foreign References:
| CN107375288A | 2017-11-24 | |||
| CN104784699A | 2015-07-22 |
Attorney, Agent or Firm:
LINDA LIU & PARTNERS (CN)
Download PDF:
Previous Patent: INTEGRIN RECEPTOR-TARGETED ANTI-CANCER CONJUGATE
Next Patent: DISPLAY PANEL AND DRIVING METHOD THEREFOR, AND DISPLAY DEVICE
Next Patent: DISPLAY PANEL AND DRIVING METHOD THEREFOR, AND DISPLAY DEVICE